(Q48155068)

9 February 2018

title

Characteristic neuroimaging in patients with tumefactive demyelinating lesions exceeding 30 mm. (English)

1 reference

9 February 2018

0 references

0 references

3

1 reference

9 February 2018

author name string

Takao Kiriyama

1

1 reference

9 February 2018

Hiroshi Kataoka

2

1 reference

9 February 2018

Yasuyo Tonomura

4

1 reference

9 February 2018

Mari Terashima

5

1 reference

9 February 2018

Masami Morikawa

6

1 reference

9 February 2018

Emi Tanizawa

7

1 reference

9 February 2018

Makoto Kawahara

8

1 reference

9 February 2018

Yoshiko Furiya

9

1 reference

9 February 2018

Kazuma Sugie

10

1 reference

9 February 2018

Kimihiko Kichikawa

11

1 reference

9 February 2018

Satoshi Ueno

12

1 reference

9 February 2018

publication date

1 April 2011

1 reference

9 February 2018

published in

Journal of Neuroimaging

1 reference

9 February 2018

volume

21

1 reference

9 February 2018

issue

2

1 reference

9 February 2018

page(s)

e69-77

1 reference

9 February 2018

Clinical and radiographic spectrum of pathologically confirmed tumefactive multiple sclerosis

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1552-6569.2010.00502.X

Characterization of tumefactive demyelinating lesions using MR imaging and in-vivo proton MR spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1552-6569.2010.00502.X

Distinguishing tumefactive demyelinating lesions from glioma or central nervous system lymphoma: added value of unenhanced CT compared with conventional contrast-enhanced MR imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1552-6569.2010.00502.X

Tumefactive demyelinating lesions: conventional and advanced magnetic resonance imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1552-6569.2010.00502.X

Spectroscopic magnetic resonance imaging of a tumefactive demyelinating lesion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1552-6569.2010.00502.X

Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1552-6569.2010.00502.X

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1552-6569.2010.00502.X

Oligoclonal IgG bands in Japanese patients with multiple sclerosis. A comparative study between isoelectric focusing with IgG immunofixation and high-resolution agarose gel electrophoresis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1552-6569.2010.00502.X

Recent neuropathological findings in MS--implications for diagnosis and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1552-6569.2010.00502.X

Haemorrhagic and perivenous encephalitis: a clinical-pathological review of 38 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1552-6569.2010.00502.X

The open ring. A new imaging sign in demyelinating disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1552-6569.2010.00502.X

Acute disseminated encephalomyelitis or multiple sclerosis: can the initial presentation help in establishing a correct diagnosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1552-6569.2010.00502.X

Intracortical lesions in multiple sclerosis: improved detection with 3D double inversion-recovery MR imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1552-6569.2010.00502.X

Proton magnetic resonance spectroscopic imaging for metabolic characterization of demyelinating plaques.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1552-6569.2010.00502.X

Increased choline levels coincide with enhanced proliferative activity of human neuroepithelial brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1552-6569.2010.00502.X

Evidence for gray matter pathology in multiple sclerosis: a neuroimaging approach.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1552-6569.2010.00502.X

Seven-Tesla magnetic resonance imaging: new vision of microvascular abnormalities in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1552-6569.2010.00502.X

The value of cerebral Doppler venous haemodynamics in the assessment of multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1552-6569.2010.00502.X

Axonal transection in the lesions of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1552-6569.2010.00502.X

Large focal tumor-like demyelinating lesions of the brain: intermediate entity between multiple sclerosis and acute disseminated encephalomyelitis? A study of 31 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1552-6569.2010.00502.X

Accumulation of hypointense lesions ("black holes") on T1 spin-echo MRI correlates with disease progression in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1552-6569.2010.00502.X

MRI features of benign multiple sclerosis: toward a new definition of this disease phenotype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1552-6569.2010.00502.X

Acute demyelinating disease. Classification and non-invasive diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1552-6569.2010.00502.X

Temporal changes and geographical differences in multiple sclerosis phenotypes in Japanese: nationwide survey results over 30 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1552-6569.2010.00502.X

10.1111/J.1552-6569.2010.00502.X

21 January 2018

Identifiers

DOI

1 reference

9 February 2018

PubMed ID

20572907

1 reference

9 February 2018